Evidence map›Paper›PMID 26147435›Full record

ArticlePloS one2015

The Crystal Structure of Thermotoga maritima Class III Ribonucleotide Reductase Lacks a Radical Cysteine Pre-Positioned in the Active Site.

Oskar Aurelius, Renzo Johansson, Viktoria Bågenholm, Daniel Lundin, Fredrik Tholander, Alexander Balhuizen, Tobias Beck, Margareta Sahlin, Britt-Marie Sjöberg, Etienne Mulliez and 1 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.5field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. New tricks for the glycyl radical enzyme family.Critical reviews in biochemistry and molecular biology · 2017
    Review
  6. Article
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 3 countries.

Oskar AureliusDept. of Biochemistry & Structural Biology, Lund University, Box 124, S-221 00 Lund, Sweden.
Renzo JohanssonDept. of Biochemistry & Structural Biology, Lund University, Box 124, S-221 00 Lund, Sweden.
Viktoria BågenholmDept. of Biochemistry & Structural Biology, Lund University, Box 124, S-221 00 Lund, Sweden.
Daniel LundinDept. of Biochemistry & Biophysics, Stockholm University, S-106 91 Stockholm, Sweden.
Fredrik TholanderDept. of Medical Biochemistry and Biophysics, Karolinska Institute, Solna, Sweden.
Alexander BalhuizenDept. of Biochemistry & Structural Biology, Lund University, Box 124, S-221 00 Lund, Sweden.
Tobias BeckDept. of Inorganic Chemistry, Georg-August Universität Göttingen, Göttingen, Germany.
Margareta SahlinDept. of Biochemistry & Biophysics, Stockholm University, S-106 91 Stockholm, Sweden.
Britt-Marie SjöbergDept. of Biochemistry & Biophysics, Stockholm University, S-106 91 Stockholm, Sweden.
Etienne MulliezLCBM, Groupe de Biocatalyse, CEA-Grenoble, Institut de Recherches en Technologies et Sciences pour le Vivant (iRTSV), 38054 Grenoble Cedex 09, France.
Derek T LoganDept. of Biochemistry & Structural Biology, Lund University, Box 124, S-221 00 Lund, Sweden.
Lund University · SEStockholm University · SECommissariat à l'Énergie Atomique et aux Énergies Alternatives · FRKarolinska Institutet · SEUniversity of Göttingen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ribonucleotide reductases (RNRs) catalyze the reduction of ribonucleotides to deoxyribonucleotides, the building blocks for DNA synthesis, and are found in all but a few organisms. RNRs use radical chemistry to catalyze the reduction reaction. Despite RNR having evolved several mechanisms for generation of different kinds of essential radicals across a large evolutionary time frame, this initial radical is normally always channelled to a strictly conserved cysteine residue directly adjacent to the substrate for initiation of substrate reduction, and this cysteine has been found in the structures of all RNRs solved to date. We present the crystal structure of an anaerobic RNR from the extreme thermophile Thermotoga maritima (tmNrdD), alone and in several complexes, including with the allosteric effector dATP and its cognate substrate CTP. In the crystal structure of the enzyme as purified, tmNrdD lacks a cysteine for radical transfer to the substrate pre-positioned in the active site. Nevertheless activity assays using anaerobic cell extracts from T. maritima demonstrate that the class III RNR is enzymatically active. Other genetic and microbiological evidence is summarized indicating that the enzyme is important for T. maritima. Mutation of either of two cysteine residues in a disordered loop far from the active site results in inactive enzyme. We discuss the possible mechanisms for radical initiation of substrate reduction given the collected evidence from the crystal structure, our activity assays and other published work. Taken together, the results suggest either that initiation of substrate reduction may involve unprecedented conformational changes in the enzyme to bring one of these cysteine residues to the expected position, or that alternative routes for initiation of the RNR reduction reaction may exist. Finally, we present a phylogenetic analysis showing that the structure of tmNrdD is representative of a new RNR subclass IIIh, present in all Thermotoga species plus a wider group of bacteria from the distantly related phyla Firmicutes, Bacteroidetes and Proteobacteria.

Indexed as

Catalytic DomainCrystallography, X-RayCysteineModels, MolecularProtein ConformationRibonucleotide ReductasesThermotoga maritimaCysteineRibonucleotide Reductases

Identifiers

PMID26147435
PMCPMC4493059
OpenAlexW1946256555

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.